Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Virology|October 11, 2013
Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activationFrances W Lai, Kyle B Stephenson, James Mahony, et al.Journal of Virology|October 31, 2008
The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesisChristopher W Brown, Kyle B Stephenson, Stephen Hanson, et al.Vaccine|March 17, 2018
Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancerMatthew J Atherton, Kyle B Stephenson, Jake K Nikota, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2009
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunityJeanette E Boudreau, Byram W Bridle, Kyle B Stephenson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Potentiating cancer immunotherapy using an oncolytic virusByram W Bridle, Kyle B Stephenson, Jeanette E Boudreau, et al.Journal for Immunotherapy of Cancer|August 15, 2020
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioningJonathan G Pol, Matthew J Atherton, Kyle B Stephenson, et al.Cancer Research|February 11, 2011
IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cellsJeanette E Boudreau, Kyle B Stephenson, Fuan Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Maraba virus as a potent oncolytic vaccine vectorJonathan G Pol, Liang Zhang, Byram W Bridle, et al.Journal for Immunotherapy of Cancer|July 19, 2019
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancerA J Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, et al.Viruses|February 27, 2020
Measles Vaccines Designed for Enhanced CD8+ T Cell ActivationElena Busch, Kristina D Kubon, Johanna K M Mayer, et al.Pageof 2